The Risk of GLP ‐1 Receptor Agonist ( GLP ‐1 RA ) Exposure in Early Pregnancy. A Call to Action: Quantifying the Impact on Pregnancy Outcomes in the United Kingdom
Diabetes, Obesity and Metabolism · 2026-07 · 28 (7) · 6455-6457
DOI: 10.1111/dom.70791 ↗Kurz gefasst
Leserbrief in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 22.04.2026. Verfasst von Michael Stedman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Res Consortium, Andover, UK. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Res Consortium, Andover, UK.
- University Hospital North Midlands, Stoke on Trent, UK.
- Keele University, Keele, UK.
- Addenbrooke's Hospital, Cambridge, UK.
- Stoke Mandeville Hospital, Aylesbury, UK.
- Kings College, London, UK.
ORCID-Profile: Martin B Whyte, Adrian Heald
Zitieren
APA
Stedman, M., Wu, P., Halsall, I., Chaudhury, N., McGowan, B., Whyte, M. B., Syed, A., & Heald, A. (2026). The Risk of GLP ‐1 Receptor Agonist ( GLP ‐1 RA ) Exposure in Early Pregnancy. A Call to Action: Quantifying the Impact on Pregnancy Outcomes in the United Kingdom. Diabetes, Obesity and Metabolism, 28(7), 6455-6457. https://doi.org/10.1111/dom.70791
Vancouver
Stedman M, Wu P, Halsall I, Chaudhury N, McGowan B, Whyte MB, et al. The Risk of GLP ‐1 Receptor Agonist ( GLP ‐1 RA ) Exposure in Early Pregnancy. A Call to Action: Quantifying the Impact on Pregnancy Outcomes in the United Kingdom. Diabetes, Obesity and Metabolism. 2026;28(7):6455-6457. doi:10.1111/dom.70791
BibTeX
@article{Stedman2026,
author = {Stedman, Michael and Wu, Pensee and Halsall, Ian and Chaudhury, Nadia and McGowan, Barbara and Whyte, Martin B and Syed, Akheel and Heald, Adrian},
title = {The Risk of GLP ‐1 Receptor Agonist ( GLP ‐1 RA ) Exposure in Early Pregnancy. A Call to Action: Quantifying the Impact on Pregnancy Outcomes in the United Kingdom},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
volume = {28},
number = {7},
pages = {6455--6457},
doi = {10.1111/dom.70791}
}
EUVIMED